<Free Webinar> AAV Symposium: Characterization and In Vivo Distribution in Gene Therapy (May 18th (Tuesday) AM 1:00 -)

Adeno-associated virus (AAV) is gaining increasing recognition in gene therapy due to its mild immune response, ability to infect a wide range of cells, and overall safety (Naso et al., 2017). However, because delivery vectors are complex, a series of robust analytical approaches are required to ensure proper assembly and packaging before product release.
<RNAscope and BaseScope in situ hybridization technology>
This introduces the visualization, detection, and quantification of the in vivo distribution of AAV and LV vectors and the expression of introduced genes in preclinical animal models.
<Capillary electrophoresis technology>
To address industry challenges, the Cell and Gene Therapy Catapult in London has developed advanced analytical platforms for the characterization of AAV vectors:
1) Assay accuracy through the implementation of next-generation technology
2) Standardization and throughput through automation
3) Inline product characterization in closed processes through the development of process analytical technology
May 18, 2021 (Tuesday) AM 1:00


Date and time | Tuesday, May 18, 2021 01:00 AM ~ 02:00 AM |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration